Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis

ISSN： 0114-5916

Source： Drug Safety, Vol.29, Iss.3, 2006-01, pp. : 231-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atrial Fibrillation due to Late Amiodarone-Induced Thyrotoxicosis

By Ibrahim Halil Kurt

Clinical Drug Investigation, Vol. 28, Iss. 8, 2008-01 ,pp. : 527-531

Adis International

Access to resources Recommend Favorite

Hyperglobulinemia in Amiodarone-induced Pneumonitis

By Mouallem Meir Antipov Natalia Mayan Haim Sela Ben Farfel Zvi

Cardiovascular Drugs and Therapy, Vol. 21, Iss. 1, 2007-02 ,pp. : 63-67

Springer Publishing Company

Access to resources Recommend Favorite

Amiodarone: Thyrotoxicosis: case report

Reactions Weekly, Vol. 1, Iss. 1333, 2011-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Amiodarone-Induced SIADH: Two Cases Report

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. : 123-125

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology

Current Radiopharmaceuticals, Vol. 10, Iss. 3, 2017-11 ,pp. : 146-154

Bentham Science Publishers

Access to resources Recommend Favorite